Literature DB >> 6448605

APD in Paget's disease of bone. Role of the mononuclear phagocyte system?

O L Bijvoet, W B Frijlink, K Jie, H van der Linden, C J Meijer, H Mulder, H C van Paassen, P H Reitsma, J te Velde, E de Vries, J P van der Wey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6448605     DOI： 10.1002/art.1780231018

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  31 in total

Review 1.  Adverse effects of bisphosphonates. A comparative review.

Authors:  S Adami; N Zamberlan
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  The effect of anti-rheumatic drugs on factors from porcine synovium inducing chondrocyte mediated cartilage degradation.

Authors:  K G Couchman; H Sheppeard
Journal:  Agents Actions       Date:  1986-10

3.  Corticosteroid induced osteoporosis in severe menstrual asthma. Steroid sparing drugs may be useful.

Authors:  A U Wells
Journal:  BMJ       Date:  1992-08-15

Review 4.  Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.

Authors:  H Fleisch
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

5.  Different schedules of administration of (3 amino-1-hydroxypropylidene)-1, 1 bisphosphonate induce different changes in pig bone remodeling.

Authors:  M C de Vernejoul; A Pointillart; C Bergot; J Bielakoff; C Morieux; A M Laval Jeantet; L Miravet
Journal:  Calcif Tissue Int       Date:  1987-03       Impact factor: 4.333

6.  The bisphosphonates HEBP and AHPrBP but not AHBP inhibit mineral mobilization and lysosomal enzyme release from mouse calvarial bones in tissue culture.

Authors:  U Lerner; A Larsson
Journal:  Experientia       Date:  1984-09-15

7.  Paget's disease of bone: five regimens of pamidronate treatment.

Authors:  T Pepersack; R Karmali; C Gillet; D François; M Fuss
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

Review 8.  Bisphosphonates in bone diseases.

Authors:  R W Sparidans; I M Twiss; S Talbot
Journal:  Pharm World Sci       Date:  1998-10

9.  Acute effects of intravenous administration of pamidronate in patients with osteoporosis.

Authors:  Mie Jin Lim; Seong Ryul Kwon; Shin-Goo Park; Won Park
Journal:  J Korean Med Sci       Date:  2010-08-14       Impact factor: 2.153

10.  Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Authors:  P H Reitsma; O L Bijvoet; M Potokar; L J van der Wee-Pals; M M van Wijk-van Lennep
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.